Explore FHI 360

Start a New Search

Search within these results

Research, monitoring and evaluation

133 Results Found

Practice Area

Research

There is an art to improving lives. And it’s in our science.
Practice Area

Education: Global

FHI 360 works side by side with ministries, communities, schools, teachers and families to create education systems that respond to the complex, dynamic and diverse needs of the people they serve. Our programs emphasize the use of data for decision...
Expertise

Research, monitoring and evaluation

To improve education around the world, we need evidence on what works. But, evidence alone is not enough. It must be integrated into policy and programming to inform change that leads to strengthened education systems and improved learning outcomes...
Publication

Achieving Financial Wellness and Freedom: GWUL CFI 2022 Evaluation Report

This report presents the results of FHI 360’s 2022 evaluation of the Greater Washington Urban League’s Center for Financial Inclusion. Clients’ experiences and self-reported measures of the center’s impact are highlighted.
Event

FHI 360 at IAS 2023, the 12th IAS Conference on HIV Science

HIV experts, researchers and policymakers from around the world will convene this month at the IAS Conference.
Tools

Meeting Targets and Maintaining Epidemic Control (EpiC): Briefs

The EpiC project offers knowledge and tools to strengthen HIV programming.
Publication

National Institute for Work and Learning 2022 Annual Report

This report describes the work of our National Institute for Work and Learning (NIWL) during the 2022 calendar year.
Publication

Quality Improvement Model to Improve MDA Coverage in Zou Department: Benin

This technical brief describes the seven components of a QI process for the implementation of MDA for NTDs in Benin.
Published research

Efficacy and safety of three antiretroviral therapy regimens started in pregnancy up to 50 weeks post partum: a multicentre, open-label, randomised, controlled, phase 3 trial
Published research

Pharmacokinetics, tolerability, and safety of doravirine and doravirine/lamivudine/tenofovir disoproxil fumarate fixed-dose combination tablets in adolescents living with HIV: Week 24 results from IMPAACT 2014

You are here

Search FHI 360

Practice Areas

Services

Content Types

Expertise Areas

Countries

Article Types

Resource Types

Research

Education: Global

Research, monitoring and evaluation

Achieving Financial Wellness and Freedom: GWUL CFI 2022 Evaluation Report

FHI 360 at IAS 2023, the 12th IAS Conference on HIV Science

Meeting Targets and Maintaining Epidemic Control (EpiC): Briefs

National Institute for Work and Learning 2022 Annual Report

Quality Improvement Model to Improve MDA Coverage in Zou Department: Benin

Efficacy and safety of three antiretroviral therapy regimens started in pregnancy up to 50 weeks post partum: a multicentre, open-label, randomised, controlled, phase 3 trial

Pharmacokinetics, tolerability, and safety of doravirine and doravirine/lamivudine/tenofovir disoproxil fumarate fixed-dose combination tablets in adolescents living with HIV: Week 24 results from IMPAACT 2014